Susquehanna International Group’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-377
Closed -$3.92K 13611
2025
Q4
$3.92K Buy
+377
New +$9.55K ﹤0.01% 12104
2023
Q4
Sell
-28
Closed -$14.1K 12822
2023
Q3
$14.1K Buy
+28
New +$24.7K ﹤0.01% 11672
2023
Q2
Sell
-16
Closed -$17.3K 12598
2023
Q1
$17.3K Buy
+16
New +$19.4K ﹤0.01% 12081
2021
Q3
Sell
-15
Closed -$85K 13140
2021
Q2
$85K Buy
+15
New +$86.4K ﹤0.01% 12151

Other funds holding ISPC

Susquehanna International Group's ISPC Position: Q1 2026 in Review

Susquehanna International Group sold out of iSpecimen (ISPC) in Q1 2026, closing a stake of 377 shares — an estimated $3.92K sold.

Susquehanna International Group first reported a position in ISPC in Q2 2021 and held it in 4 quarters. The position peaked at $85K in Q2 2021. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • Susquehanna International Group reported no remaining iSpecimen position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 377 iSpecimen shares in Q1 2026, an estimated $3.92K.
  • Susquehanna International Group first reported a position in iSpecimen in Q2 2021 and held it in 4 quarters.
  • Susquehanna International Group's iSpecimen position peaked at $85K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.